1型糖尿病多次注射治疗中持续葡萄糖监测与血糖控制及低血糖的关系
该研究分析DIAMOND和HypoDE研究中1型糖尿病多次注射治疗患者的CGM数据,探讨血糖控制(HbA1c和平均葡萄糖)与低血糖时间百分比的关系。发现平均葡萄糖与低血糖呈非线性关系,实时CGM可减弱此关系,在较低HbA1c和平均葡萄糖时影响最显著。
要点
- 实时CGM可减弱血糖控制与低血糖之间的反向关系
- 平均葡萄糖与低血糖呈非线性关系,低值处关系最陡
- 实时CGM在较低HbA1c和平均葡萄糖时降低低血糖风险最明显
核心结论
- 使用实时CGM可减弱血糖控制与低血糖的关系,在较低HbA1c和平均葡萄糖的多次注射治疗1型糖尿病患者中影响最大。
研究设计与样本
- 分析DIAMOND和HypoDE研究中干预阶段(实时CGM)和对照阶段(自我血糖监测)的CGM数据。
主要发现
- 基线时平均葡萄糖与低血糖呈非线性关系,平均葡萄糖较低时关系最陡。
- 实时CGM降低所有阈值(3.9 mmol/L和3.0 mmol/L)的低血糖暴露,并减弱整体血糖与低血糖的关系。
- 在自我血糖监测组和实时CGM组中,低血糖暴露随整体血糖范围变化,但实时CGM组关系较弱。
关键数值与推荐
- 低血糖阈值定义为3.9 mmol/L(70 mg/dL)和3.0 mmol/L(54 mg/dL)。
临床怎么用
- 对于多次注射治疗的1型糖尿病患者,尤其是低血糖高风险者,使用实时CGM有助于在良好血糖控制的同时减少低血糖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The inverse relationship between overall glucose control and hypoglycemia risk is weakened by the use of real-time continuous glucose monitoring (rtCGM). We assess the relationship between glucose control and hypoglycemia in people with type 1 diabetes using multiple-dose injection (MDI) regimens, including those at highest risk of hypoglycemia. RESEARCH DESIGN AND METHODS: CGM data from the intervention (rtCGM) and control (self-monitored blood glucose [SMBG]) phases of the Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes (DIAMOND) and HypoDE studies were analyzed. The relationship between glucose control (HbA1c and mean rtCGM glucose levels) and percentage time spent in hypoglycemia was explored for thresholds of 3.9 mmol/L (70 mg/dL) and 3.0 mmol/L (54 mg/dL), and ANOVA across the range of HbA1c and mean glucose was performed. RESULTS: A nonlinear relationship between mean glucose and hypoglycemia was identified at baseline, with the steepest relationship seen at lower values of mean glucose. The use of rtCGM reduces the exposure to hypoglycemia at all thresholds and flattens the relationship between overall glucose and hypoglycemia, with the most marked impact at lower values of mean glucose and HbA1c. Exposure to hypoglycemia varied at all thresholds across the range of overall glucose at baseline, in the SMBG group, and with rtCGM, but the relationships were weaker in the rtCGM group. CONCLUSIONS: Use of rtCGM can flatten and attenuate the relationship between overall glucose control and hypoglycemia, exerting its greatest impact at lower values of HbA1c and mean glucose in people with type 1 diabetes using MDI regimens and at highest risk of hypoglycemia.
引用
- Oliver N, Gimenez M, Calhoun P, et al. Continuous Glucose Monitoring in People With Type 1 Diabetes on Multiple-Dose Injection Therapy: The Relationship Between Glycemic Control and Hypoglycemia. Diabetes Care. 2019. PMID: 31530662. doi:10.2337/dc19-0977
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。